These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 7024644

  • 21. Adjuvant chemotherapy for breast cancer: an overview of NSABP findings.
    Fisher B, Redmond C, Elias EG, Evans J, Foster R, Jochimsen P, Lawrence W, Lerner H, LiCalzi N, Margolese R, Poisson R, Sachs S, Shibata H, Sutherland C, Wallack M.
    Int Adv Surg Oncol; 1982; 5():65-90. PubMed ID: 7047408
    [No Abstract] [Full Text] [Related]

  • 22. Role of chemotherapy in stage I breast cancer.
    Bonadonna G, Valagussa P.
    Important Adv Oncol; 1989; ():151-60. PubMed ID: 2651285
    [No Abstract] [Full Text] [Related]

  • 23. Adjuvant chemotherapy in stage I breast cancer. More harm than benefit.
    Mueller CB.
    Can Fam Physician; 1993 Oct; 39():2185-9. PubMed ID: 8219866
    [Abstract] [Full Text] [Related]

  • 24. Adjuvant chemotherapy for early-stage breast cancer.
    McArthur HL, Hudis CA.
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):207-22. PubMed ID: 17512445
    [Abstract] [Full Text] [Related]

  • 25. Adjuvant systemic therapy for lymph node-negative breast cancer less than or equal to 1 cm.
    Russell CA.
    Curr Womens Health Rep; 2002 Apr; 2(2):134-9. PubMed ID: 12116603
    [Abstract] [Full Text] [Related]

  • 26. Estrogen/postmenopausal women. NIH consensus development.
    J Kans Med Soc; 1982 Oct; 83(10):511-3. PubMed ID: 6754835
    [No Abstract] [Full Text] [Related]

  • 27. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.
    Buchholz TA, Lehman CD, Harris JR, Pockaj BA, Khouri N, Hylton NF, Miller MJ, Whelan T, Pierce LJ, Esserman LJ, Newman LA, Smith BL, Bear HD, Mamounas EP.
    J Clin Oncol; 2008 Feb 10; 26(5):791-7. PubMed ID: 18258988
    [Abstract] [Full Text] [Related]

  • 28. Current status of post-chemotherapy tamoxifen in early breast cancer.
    Tolcher AW.
    Oncology (Williston Park); 1994 Nov 10; 8(11):39-43; discussion 47-9. PubMed ID: 7826838
    [Abstract] [Full Text] [Related]

  • 29. The role of the National Cancer Institute in drug development.
    Doroshow J.
    Clin Adv Hematol Oncol; 2005 Apr 10; 3(4):257-8. PubMed ID: 16166997
    [No Abstract] [Full Text] [Related]

  • 30. [Adjuvant therapy in breast neoplasms].
    Senn HJ.
    Aktuelle Probl Chir Orthop; 1982 Apr 10; 22():52-60. PubMed ID: 6121514
    [No Abstract] [Full Text] [Related]

  • 31. Adjuvant chemotherapy of breast cancer. Summary of an NIH consensus statement.
    Br Med J; 1980 Sep 13; 281(6242):724-5. PubMed ID: 7000275
    [No Abstract] [Full Text] [Related]

  • 32. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S, Wittes R.
    Cancer Treat Rep; 1984 Jan 13; 68(1):77-85. PubMed ID: 6362870
    [No Abstract] [Full Text] [Related]

  • 33. Investigational new drugs in cancer chemotherapy.
    Peterson BA, Briscoe K.
    Minn Med; 1979 Jul 13; 62(7):536-8. PubMed ID: 386073
    [No Abstract] [Full Text] [Related]

  • 34. Cancer research. Budget pressure puts high-profile study in doubt.
    Marshall E.
    Science; 2007 Mar 16; 315(5818):1477. PubMed ID: 17363634
    [No Abstract] [Full Text] [Related]

  • 35. Adjuvant chemotherapy of breast cancer.
    Carroll RR.
    J Med Assoc Ga; 1985 Nov 16; 74(11):758-9. PubMed ID: 3908609
    [No Abstract] [Full Text] [Related]

  • 36. The National Institutes of Health Consensus Development Conference: Adjuvant Therapy for Breast Cancer. Bethesda, Maryland, USA. November 1-3, 2000. Proceedings.
    J Natl Cancer Inst Monogr; 2001 Nov 16; (30):1-152. PubMed ID: 12083020
    [No Abstract] [Full Text] [Related]

  • 37. NIH/NCI Consensus Development Meeting on breast cancer screening. Response of the National Cancer Institute.
    Yale J Biol Med; 1978 Nov 16; 51(1):9-11. PubMed ID: 676352
    [No Abstract] [Full Text] [Related]

  • 38. NIH Consensus development conference summary: CEA as a cancer marker.
    J Tenn Med Assoc; 1982 Jan 16; 75(1):24-5. PubMed ID: 7087455
    [No Abstract] [Full Text] [Related]

  • 39. NCI's breast cancer clinical alert: rationale and results.
    DeVita VT, Hubbard SM.
    Resid Staff Physician; 1989 Jul 15; 35(8):49-55. PubMed ID: 10303742
    [Abstract] [Full Text] [Related]

  • 40. Long-term tamoxifen trial halted.
    Marshall E.
    Science; 1995 Dec 08; 270(5242):1562. PubMed ID: 7502061
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.